Title:
ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND METHODS OF USE
Document Type and Number:
WIPO Patent Application WO/2021/055577
Kind Code:
A3
Abstract:
The invention provides anti-KLK7 antibodies, anti-KLK5 antibodies, anti-KLK5/KLK7 multispecific antibodies, and methods of using the same.
Inventors:
KOERBER JAMES THOMAS (US)
LEE WYNE PUN (US)
YI TANGSHENG (US)
ZHANG JUAN (US)
AUSTIN CARY DEAN (US)
CHIU CECILIA P C (US)
CHAVARRIA-SMITH JOSEPH EDWARD (US)
SUDHAMSU JAWAHAR (US)
LEE WYNE PUN (US)
YI TANGSHENG (US)
ZHANG JUAN (US)
AUSTIN CARY DEAN (US)
CHIU CECILIA P C (US)
CHAVARRIA-SMITH JOSEPH EDWARD (US)
SUDHAMSU JAWAHAR (US)
Application Number:
PCT/US2020/051233
Publication Date:
April 29, 2021
Filing Date:
September 17, 2020
Export Citation:
Assignee:
GENENTECH INC (US)
HOFFMANN LA ROCHE (CH)
HOFFMANN LA ROCHE (CH)
International Classes:
C07K16/40; A61K39/395; A61P17/00
Domestic Patent References:
WO1995000651A1 | 1995-01-05 | |||
WO2004075723A2 | 2004-09-10 | |||
WO2002044736A2 | 2002-06-06 |
Other References:
ANONYMOUS: "Human Kallikrein 7 Antibody", RNDSYSTEMS.COM, 7 February 2018 (2018-02-07), pages 1, XP055756013, Retrieved from the Internet [retrieved on 20201202]
PETR KASPAREK ET AL: "KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype", PLOS GENETICS, vol. 13, no. 1, 1 January 2017 (2017-01-01), pages e1006566, XP055595662, DOI: 10.1371/journal.pgen.1006566
PETR KASPAREK ET AL: "KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype", PLOS GENETICS, vol. 13, no. 1, 1 January 2017 (2017-01-01), pages e1006566, XP055595662, DOI: 10.1371/journal.pgen.1006566
Attorney, Agent or Firm:
SCARR, Rebecca B. et al. (US)
Download PDF:
Previous Patent: COMBINATION OF MODAFINIL AND AN AMPAKINE FOR IMPROVING COGNITION
Next Patent: INTEGRATED CLOSURE AND CONTAINER
Next Patent: INTEGRATED CLOSURE AND CONTAINER